Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Free Cash Flow (2018 - 2025)

Historic Free Cash Flow for Abvc Biopharma (ABVC) over the last 13 years, with Q3 2025 value amounting to -$133257.0.

  • Abvc Biopharma's Free Cash Flow fell 32124.69% to -$133257.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 4760.56%. This contributed to the annual value of -$1.8 million for FY2024, which is 5700.75% up from last year.
  • Latest data reveals that Abvc Biopharma reported Free Cash Flow of -$133257.0 as of Q3 2025, which was down 32124.69% from -$894174.0 recorded in Q2 2025.
  • In the past 5 years, Abvc Biopharma's Free Cash Flow registered a high of $60230.0 during Q3 2024, and its lowest value of -$3.5 million during Q2 2022.
  • Over the past 5 years, Abvc Biopharma's median Free Cash Flow value was -$899827.0 (recorded in 2023), while the average stood at -$1.2 million.
  • As far as peak fluctuations go, Abvc Biopharma's Free Cash Flow crashed by 57396.94% in 2021, and later surged by 10641.05% in 2024.
  • Abvc Biopharma's Free Cash Flow (Quarter) stood at -$2.5 million in 2021, then skyrocketed by 81.73% to -$461158.0 in 2022, then increased by 6.66% to -$430463.0 in 2023, then tumbled by 63.11% to -$702134.0 in 2024, then skyrocketed by 81.02% to -$133257.0 in 2025.
  • Its last three reported values are -$133257.0 in Q3 2025, -$894174.0 for Q2 2025, and -$539833.0 during Q1 2025.